• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[视网膜母细胞瘤患者免疫抑制酸性蛋白(IAP)的定量测定]

[Quantitative measurement of IAP (immunosuppressive acidic protein) in patients with retinoblastoma].

作者信息

Takahashi R, Yamaguchi K, Tamai M

机构信息

Department of Ophthalmology, Tohoku University School of Medicine, Sendai, Japan.

出版信息

Nippon Ganka Gakkai Zasshi. 1990 Jun;94(6):593-6.

PMID:2403045
Abstract

Immunosuppressive acidic protein (IAP) is a useful tumor marker for evaluating clinical course, therapeutic effectiveness, and prognosis of patients with various malignant tumors. In this report, we examined the serum IAP levels in 20 patients with retinoblastomas. In 6 cases, both preoperative and postoperative IAP values were examined, and in 14 cases the levels of this protein were postoperatively followed. Although 2 of 6 cases had higher levels of IAP than 500 micrograms/ml preoperatively, they had decreased within the normal range (less than 500 micrograms/ml) postoperatively. The mean IAP levels at 1-2 weeks before, 1-2 weeks after and 1 month after surgery were 422 +/- 225.1 micrograms/ml, 221 +/- 62.6 micrograms/ml, and 297 +/- 89.8 micrograms/ml, respectively, that means IAP decreased after enucleation. In 14 cases in which this protein was examined only postoperatively the value was 314.5 +/- 91.6 micrograms/ml. In one case with a level of 856 micrograms/ml of IAP before enucleation, pathological examination revealed invasion of retinoblastoma cells to the optic nerve and orbital fat. The high level of IAP might be related to the extraocular invasion. Since the level of serum IAP decreased after enucleation, these results suggested that immunological activities might change, even though tumor cells grew within the blood retinal barrier.

摘要

免疫抑制酸性蛋白(IAP)是评估各种恶性肿瘤患者临床病程、治疗效果及预后的一种有用的肿瘤标志物。在本报告中,我们检测了20例视网膜母细胞瘤患者的血清IAP水平。其中6例患者术前和术后均检测了IAP值,14例患者术后对该蛋白水平进行了随访。虽然6例中有2例术前IAP水平高于500微克/毫升,但术后降至正常范围(低于500微克/毫升)。手术前1 - 2周、手术后1 - 2周和1个月时的平均IAP水平分别为422±225.1微克/毫升、221±62.6微克/毫升和297±89.8微克/毫升,这表明眼球摘除术后IAP降低。在仅术后检测该蛋白的14例患者中,其值为314.5±91.6微克/毫升。在1例眼球摘除术前IAP水平为856微克/毫升的患者中,病理检查显示视网膜母细胞瘤细胞侵犯视神经和眶脂肪。IAP水平高可能与眼外侵犯有关。由于眼球摘除术后血清IAP水平降低,这些结果提示即使肿瘤细胞在血视网膜屏障内生长,免疫活性可能也会发生变化。

相似文献

1
[Quantitative measurement of IAP (immunosuppressive acidic protein) in patients with retinoblastoma].[视网膜母细胞瘤患者免疫抑制酸性蛋白(IAP)的定量测定]
Nippon Ganka Gakkai Zasshi. 1990 Jun;94(6):593-6.
2
Immunosuppressive acidic protein in intraocular fluids.眼内液中的免疫抑制酸性蛋白。
Jpn J Ophthalmol. 1994;38(4):388-91.
3
[Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
Hinyokika Kiyo. 1989 Oct;35(10):1647-52.
4
[Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
Rinsho Byori. 1990 Mar;38(3):255-9.
5
A comparative study of immunosuppressive acidic protein (IAP), CA 125 and acute-phase proteins as parameters for ovarian cancer monitoring.
Neoplasma. 1988;35(2):215-20.
6
[The immunosuppressive acidic protein in the vitreous of fundus diseases].[眼底疾病玻璃体中的免疫抑制酸性蛋白]
Nippon Ganka Gakkai Zasshi. 1992 Apr;96(4):506-10.
7
[Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].[不同疾病状态下免疫抑制酸性蛋白(IAP)的血清水平及其临床意义]
Nihon Geka Gakkai Zasshi. 1984 Apr;85(4):283-99.
8
[Immunosuppressive acidic protein in patients with gynecologic cancer].妇科癌症患者体内的免疫抑制酸性蛋白
Nihon Sanka Fujinka Gakkai Zasshi. 1983 May;35(5):605-11.
9
Serum immunosuppressive acidic protein levels in blackfoot disease patients and cancer patients.
J Formos Med Assoc. 1990 Apr;89(4):255-8.
10
[Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
Gan To Kagaku Ryoho. 1982 Oct;9(10):1755-64.